Video: Sylvie Grégoire of Shire on corporate social responsibility and #RareDiseases

In Uncategorized by Caroline Hornby

Sylvie Gregoire of shire on social responsibility and rare disease Dr. Sylvie Grégoire, President of Shire Human Genetic Therapies, presented at last year’s World Orphan Drug Congress USA on the topic ‘The social responsibility of companies working with orphan diseases.’

Do you want to learn more about:

  • Differentiating the orphan drug market from the traditional pharma market
  • Focusing on patients and personalized marketing: a paradigm shift to market drugs in orphan diseases
  • Industry’s responsibility to provide patients with access to orphan drugs

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!